FOMDWebPartPage

2011 Publications

  1. Mengel M, Mihatsch M, Halloran PF. Histological characteristics of calcineurin inhibitor toxicity--there is no such thing as specificity! Am J Transplant. 2011 Dec;11(12):2549-50.
  2. Gabardi S, Halloran PF, Friedewald J. Managing risk in developing transplant immunosuppressive agents: the new regulatory environment. Am J Transplant. 2011 Sep;11(9):1803-9.
  3. Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, de Freitas DG, Guembes-Hidalgo L, Sis B, Haller H, Halloran PF. The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course. Am J Transplant. 2011 Apr;11(4):708-18.
  4. Sellarés J, de Freitas DG, Mengel M, Sis B, Hidalgo LG, Matas AJ, Kaplan B, Halloran PF. Inflammation lesions in kidney transplant biopsies: association with survival is due to the underlying diseases. Am J Transplant. 2011 Mar;11(3):489-99.